Chuangmei Pharmaceutical

I: Investor Relations

Announcements and Circulars

The current position: Home>Investor Relations>Announcements and Circulars

Year

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

152024-03

PROFIT WARNING
022024-01

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
012023-12

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
012023-11

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
202023-10

Constitutional Documents
202023-10

POLL RESULTS OF THE 2023 SECOND EXTRAORDINARY GENERAL MEETING HELD ON 20 OCTOBER 2023
052023-10

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
212023-09

2023 INTERIM REPORT
212023-09

FORM OF PROXY FOR USE AT THE 2023 SECOND EXTRAORDINARY GENERAL MEETING TO BE HELD ON 20 OCTOBER 2023 OR AT ANY ADJOURNMENT THEREOF
212023-09

NOTICE OF THE 2023 SECOND EXTRAORDINARY GENERAL MEETING
212023-09

(1)PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION；(2)PROPOSED AMENDMENTS TO THE RULES OF PROCEDURES FOR SHAREHOLDERS’ MEETINGS;(3)PROPOSED AMENDMENTS TO THE RULES OF PROCEDURES FOR BOARD MEETINGS;AND NOTICE OF THE 2023 SECOND EXTRAORDINARY GENERAL MEETING
202023-09

(1) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION；(2) PROPOSED AMENDMENTS TO THE RULES OF PROCEDURES FOR SHAREHOLDERS’ MEETINGS; AND (3) PROPOSED AMENDMENTS TO THE RULES OF PROCEDURES FOR BOARD MEETINGS

1 2 3 4 5

The Enterprise OA